Kairos Pharma Ltd. (NYSE KAPA) Revenue and Competitors

Los Angeles, CA USA

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Kairos Pharma Ltd. (NYSE KAPA) has 1 Employees.(i)
  • Kairos Pharma Ltd. (NYSE KAPA) grew their employee count by 0% last year.

Kairos Pharma Ltd. (NYSE KAPA)'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is Kairos Pharma Ltd. (NYSE KAPA)?

Kairos Pharma is focused on developing cutting-edge therapeutics for cancer patients that reverse the inhibitory effects of cancer on the immune system. By doing so, we seek to transform the way cancer is treated by positively impacting patient outcomes while maintaining quality of life.

keywords:N/A

N/A

Total Funding

1

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M1-80%N/A
#2
$0M1-75%$24.3M
#3
$0M1-50%$6.9M
#4
$0M10%$120.7M
#5
N/A10%N/A